Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled time : 04:00 save search
VFS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that VinFast Auto Ltd. (f/k/a Black Spade Acquisition Co.) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-04-16 (Crawled : 04:00) - prnewswire.com
VFS | News | $2.69 -1.1% 1.9M
|
|
| O: -12.91%
H: 0.0%
C: 0.0%
CKPT | $1.635 -2.1% 300K
|
Health Technology
|
| O: 2.31%
H: 0.0%
C: -4.52%
acquisition
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-04-16 (Crawled : 04:00) - prnewswire.com
QDEL | News M | $38.88 0.44% 400K
|
Health Technology
|
| O: -2.85%
H: 0.27%
C: -1.87%
CKPT | $1.635 -2.1% 300K
|
Health Technology
|
| O: 2.31%
H: 0.0%
C: -4.52%
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
Published: 2024-04-12 (Crawled : 04:00) - globenewswire.com
NRIX 1 d | $14.31 1.63% 220K
|
Health Technology
|
| O: -1.32%
H: 2.19%
C: 1.76%
million offering therapeutics
Alterity Therapeutics Receives a $3.9 million Research & Development Tax Incentive Refund
Published: 2024-03-26 (Crawled : 04:00) - alteritytherapeutics.com
ATHE | News | $2.07 2.99% 15K
|
Health Technology
|
| O: 2.34%
H: 5.11%
C: 2.86%
million research therapeutics
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2.06 billion between 2022 and 2027, Technavio
Published: 2024-03-26 (Crawled : 04:00) - prnewswire.com
ADCT | $4.74 -4.44% 150K
|
Health Technology
|
| O: 0.0%
H: 8.1%
C: 3.57%
therapeutics market
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million, 42% of market growth is expected in North America, Technavio
Published: 2024-03-12 (Crawled : 04:00) - prnewswire.com
ELDN | $1.57 69K
|
Manufacturing
|
| O: 1.73%
H: 1.7%
C: -7.39%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
DNLI | $16.69 -0.77% 430K
|
Health Technology
|
| O: -0.6%
H: 0.74%
C: -3.66%
BCLI | $0.497 -8.1% 770K
|
Health Technology
|
| O: -2.43%
H: 2.8%
C: -4.02%
BIIB | $190.805 -0.71% 870K
|
Health Technology
|
| O: -0.32%
H: 0.18%
C: -0.86%
expected sclerosis treatment growth market
Kyverna Therapeutics Announces Pricing of Upsized Initial Public Offering
Published: 2024-02-08 (Crawled : 04:00) - prnewswire.com
MS | News 0 d | $90.79 0.79% 1.7M
|
Finance
|
| O: -0.37%
H: 0.64%
C: -0.04%
offering therapeutics
Europe Gene Editing Technologies Market Report 2024: Analysis and Forecasts 2023-2032 - Leveraging Collaboration as a Major Key Strategies to Create Opportunities
Published: 2024-02-07 (Crawled : 04:00) - prnewswire.com
CRSP M | $56.73 2.11% 660K
|
Health Technology
|
| O: 0.18%
H: 0.31%
C: -1.91%
CLLS | $2.46 3.3K
|
Health Technology
|
| O: -0.67%
H: 1.01%
C: 1.01%
europe report collaboration key market
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
Published: 2024-01-31 (Crawled : 04:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 1.16%
H: 0.46%
C: -5.29%
meeting therapeutics results
Base Editing Market to Increase by USD 307.66 million, 13.51% YOY growth expected in 2024 - Technavio
Published: 2024-01-25 (Crawled : 04:00) - prnewswire.com
BEAM | $24.08 -0.95% 590K
|
Health Technology
|
| O: 1.21%
H: 3.19%
C: -0.56%
expected growth market
Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock
Published: 2024-01-05 (Crawled : 04:00) - globenewswire.com
MS | News 0 d | $90.79 0.79% 1.7M
|
Finance
|
| O: 0.07%
H: 1.87%
C: 1.12%
DYN | $23.975 -3.41% 410K
|
Health Technology
|
| O: -8.25%
H: 3.49%
C: 0.96%
million offering therapeutics
Voyager Therapeutics Announces Pricing of Public Offering
Published: 2024-01-05 (Crawled : 04:00) - globenewswire.com
VYGR | $7.76 0.26% 210K
|
Health Technology
|
| O: -17.62%
H: 0.9%
C: -0.9%
offering therapeutics
Sjogrens Syndrome Therapeutics Market report from 2022-2027 by Technavio - The market size to grow by USD 691.09 million during the forecast period
Published: 2023-12-15 (Crawled : 04:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -1.81%
H: 0.0%
C: -1.79%
GSK | $39.2 -1.01% 1.2M
|
Health Technology
|
| O: -1.84%
H: 0.3%
C: -1.16%
report therapeutics market
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BCLI
Published: 2023-12-08 (Crawled : 04:00) - prnewswire.com
DMTK 4 | $0.62 4.73% 63K
|
Health Technology
|
| O: -2.76%
H: 6.38%
C: 4.26%
BCLI | $0.497 -8.1% 770K
|
Health Technology
|
| O: 0.0%
H: 3.56%
C: -9.77%
first deadline cell therapeutics
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
Published: 2023-11-29 (Crawled : 04:00) - globenewswire.com
VERV | $6.63 -1.63% 560K
|
Professional, Scientific, and T...
|
| O: -11.15%
H: 13.21%
C: 5.66%
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
offering therapeutics
Karuna Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KarXT for the Treatment of Schizophrenia
Published: 2023-10-10 (Crawled : 04:00) - zailaboratory.com
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 0.93%
H: 1.45%
C: 0.77%
drug food treatment schizophrenia application therapeutics
» Dirty Honey at Schenectady's Frog Alley among weekend top … – The Daily Gazette
Published: 2023-10-04 (Crawled : 04:00) - spacfeed.com
KTRA | $0.101 -2.7% 970K
|
Distribution Services
|
| O: -7.67%
H: 5.14%
C: 0.0%
Biologic therapeutics market size to increase by USD 286.12 billion from 2022 to 2027: Introduction of biosimilars to drive growth - Technavio
Published: 2023-05-10 (Crawled : 04:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -1.66%
H: 0.0%
C: 0.0%
AZNCF | $140.15 560
|
Health Technology
|
| O: 0.63%
H: 0.64%
C: 0.64%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.24%
H: 0.0%
C: 0.0%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: -1.03%
H: 0.26%
C: 0.01%
GSK | $39.2 -1.01% 1.2M
|
Health Technology
|
| O: -0.03%
H: 0.38%
C: 0.25%
BAX | News | $39.44 -0.2% 1.1M
|
Health Technology
|
| O: 0.56%
H: 1.99%
C: 1.2%
ABBV | $165.54 0.78% 2.2M
|
Health Technology
|
| O: -0.21%
H: 0.32%
C: -0.07%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -1.75%
H: 0.0%
C: 0.0%
BMRN | News S | $91.03 0.62% 280K
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: -0.92%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: -0.53%
H: 0.5%
C: 0.25%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.2%
H: 0.05%
C: -0.33%
therapeutics growth market
Hospital Infection Therapeutics Market to grow at a CAGR of 4.98% from 2022 to 2027, antibiotics to be a major segment for the growth of the market - Technavio
Published: 2023-03-16 (Crawled : 04:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -0.07%
H: 1.96%
C: 0.56%
AZNCF | $140.15 560
|
Health Technology
|
| O: 0.77%
H: 1.14%
C: 0.96%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.16%
H: 0.73%
C: 0.73%
VTRS | $11.12 0.18% 1.1M
|
Health Technology
|
| O: -1.58%
H: 1.93%
C: 1.6%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.18%
H: 0.77%
C: 0.64%
GSK | $39.2 -1.01% 1.2M
|
Health Technology
|
| O: -0.89%
H: 1.64%
C: 1.62%
ABBV | $165.54 0.78% 2.2M
|
Health Technology
|
| O: -0.56%
H: 1.78%
C: 1.37%
ABT | News | $104.91 -0.94% 2.8M
|
Health Technology
|
| O: -0.76%
H: 2.29%
C: 2.03%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: 0.36%
H: 1.87%
C: 1.81%
infection antibiotics therapeutics growth market
Calliditas Announces Primary Endpoint Successfully Met in Phase 3 NefIgArd Trial Evaluating Nefecon® in IgA Nephropathy
Published: 2023-03-13 (Crawled : 04:00) - prnewswire.com
CALT | $18.3 -2.35% 4.5K
|
Health Technology
|
| O: 34.28%
H: 3.54%
C: -0.79%
nefecon nephropathy trial nefigard
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
INVO | $1.36 78.95% 3.6M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
HOLO | $2.86 27.68% 28M
|
SWVL | $9.64 27.35% 200K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.